Is It Time for Some New Approaches for Treating Advanced Ovarian Cancer?
Author:
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
http://academic.oup.com/jnci/article-pdf/98/15/1024/7687501/djj321.pdf
Reference19 articles.
1. Balvert-Locht HR, Coebergh JW, Hop WC, Brolman HA, Crommelin M, van Wijck DJ, et al. Improved prognosis of ovarian cancer in The Netherlands during the period 1975–1985: a registry-based study. Gynecol Oncol1991 ; 42 : 3 –8.
2. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med1996 ; 334 : 1 –6.
3. Vasey PA, Atkinson R, Coleman R, Crawford M, Cruikshank M, Eggleton P, et al. Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer. Br J Cancer2001 ; 84 : 170 –8.
4. Sandercock J, Parmar M, Torri V, Qian W. First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence. Br J Cancer2002 ; 87 : 815 –24.
5. Pfisterer J, Weber B, Reuss A, Kimmig R, du Bois A, Wagner U, et al. Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a Gynecologic Cancer Intergroup trial of the AGO-OVAR and GINECO. J Natl Cancer Inst2006 ; 98 : 1036 –45.
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Trophinin is a potent prognostic marker of ovarian cancer involved in platinum sensitivity;Biochemical and Biophysical Research Communications;2007-08
2. Trends in population-based cancer survival in Germany: to what extent does progress reach older patients?;Annals of Oncology;2007-07
3. Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signaling;Molecular Cancer Therapeutics;2007-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3